Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making

Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) within 3 h of symptom onset is currently approved for treatment of acute ischemic stroke. Those who present within 3 h and have a vascular occlusion and a good CT scan are the ideal candidates for thrombolysis. Clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sylaja, P. N., Demchuk, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204111/
https://www.ncbi.nlm.nih.gov/pubmed/35721450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204111/
https://www.ncbi.nlm.nih.gov/pubmed/35721450

Ejemplares similares